Ireland· IE-PA-PA1025/009/001

Skinoren 15% Gel

A azelaic acid product containing azelaic acid, registered in Ireland by LEO Pharma A/S. The same ATC class is registered in 12 of our 19 countries.

ATC D10AX03

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedSkinoren 15% GelATCD10AX03REGISTER NO.IE-PA-PA1025/009/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Azelaic acid is registered in 12 of 19 countries.

Countries holding a registration under ATC D10AX03 (azelaic acid), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Azelaic acid · ATC D10AX03

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Azelaic acid
Manufacturer
LEO Pharma A/S
Country
Ireland (IE)
ATC code
D10AX03
ATC class
Azelaic acid
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1025/009/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for azelaic acid.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Azelaic acid · interactions on record

5 records

  • 2 moderate
  • 3 info

Most severe, free to view

  • IsotretinoinD10AD04moderate
  • IsotretinoinD10BA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Azelaic acid in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All azelaic acid products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Finacea, Skinoren
  • Belgium · Skinoren
  • Bulgaria · Скинорен, Финацеа
  • Cyprus · Skinoren
  • Czechia · Skinoren
  • Germany · Skinoren
  • Denmark · Finacea, Skinoren
  • Estonia · Finacea, Skinoren
  • Spain · Finacea, Zeliderm
  • Finland · Skinoren
  • France · Finacea, Skinoren
  • United Kingdom (Northern Ireland) · Finacea, Skinoren
  • Greece · Arbonid, Azelderm
  • Croatia · Skinoren
  • Hungary · Finacea, Skinoren
  • Italy · Finacea, Skinoren
  • Lithuania · Finacea, Skinoren
  • Luxembourg · Skinoren
  • Latvia · Finacea, Skinoren
  • Norway · Finacea, Skinoren
  • Poland · Skinoren, Skinoren Rosacea
  • Portugal · Skinoren
  • Romania · Skinoren
  • Sweden · Azelainsyra Evolan, Finacea
  • Slovenia · Skinoren
  • Slovakia · Finacea, Skinoren

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdcd08a0-e4f5-4c04-b4ae-4a9d3b2de542
GET /v1/drugs/cdcd08a0-e4f5-4c04-b4ae-4a9d3b2de542?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gel",
  "routes": [
    "Topical"
  ],
  "source": "hpra",
  "atc_all": [
    "D10AX",
    "D10AX03"
  ],
  "strength": null,
  "pa_number": "PA1025/009/001",
  "substances": [
    "Azelaic acid"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "30/06/2003",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about azelaic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.